Skip to main content

Month: March 2025

Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary

Company is strategically positioned following the recent $20 million capital raise, enhancing manufacturing capabilities to accelerate qualification and shipments under existing agreements NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) — Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our Company’s trajectory in 2025 and beyond. With the successful closing of a $20 million financing in January, we strengthened our balance sheet by securing working capital for operating and capital expenditures and paid down our debt to zero. We believe that we are now well-positioned to advance our operations in Hungary through the previously announced SoloGard and SecureGard agreements, alongside ongoing business development initiatives in the U.S. We...

Continue reading

G-III Apparel Group Announces Date for Fourth Quarter and Full Year Fiscal 2025 Results

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and marketing, today announced that it will release its fourth quarter and full year fiscal 2025 earnings before the market opens on Thursday, March 13, 2025. Management will host a conference call to discuss results at 8:30 a.m. ET that same day, followed by a question and answer session for the investment community. To participate via telephone, please register in advance at this link: https://register.vevent.com/register/BI238526a995aa4b8c845f1bacc37fb5ec. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the...

Continue reading

Sachem Capital Corp. Announces Dividend of $0.05 Per Share

– Sets Date for Fourth Quarter 2024 Earnings Release and Conference Call – BRANFORD, Conn., March 06, 2025 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (the “Company”) announced today that its board of directors authorized and declared a quarterly dividend of $0.05 per common share to be paid to shareholders of record as of the close of trading on the NYSE American on March 17, 2025. The dividend is payable on March 31, 2025. The Company expects to release its fourth quarter 2024 financial results before market open on Thursday, March 27, 2025. A webcast and conference call to discuss the results will be held on Thursday, March 27, 2025, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company’s website www.sachemcapitalcorp.com. To...

Continue reading

AYR Wellness Reports Fourth Quarter and Full Year 2024 Results

MIAMI, March 06, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, is reporting financial results for the fourth quarter and full year ended December 31, 2024. Unless otherwise noted, all results are presented in U.S. dollars. Steven M. Cohen, Interim CEO of AYR, said, “Over the past quarter we have made crucial steps towards reorienting the business to reflect our forward-looking vision of AYR. And while our fourth quarter and full year results reflected ongoing macroeconomic pressures and company-specific challenges that impacted revenue and profitability, we remain confident that sustained growth and enhanced profitability are achievable within our footprint through disciplined cost reductions, streamlined operations,...

Continue reading

Xunlei Limited Schedules 2024 Unaudited Fourth Quarter and Fiscal Year Earnings Release on March 13, 2025

SHENZHEN, China, March 06, 2025 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024 on March 13, 2025 before market open. The earnings press release will be available on the Company’s investor relations page at http://ir.xunlei.com. Conference Call Xunlei’s management will host a conference call at 8:00 a.m. U.S. Eastern Time on March 13, 2025 (8:00 p.m. Beijing/Hong Kong Time), to discuss the Company’s quarterly and fiscal year results and recent business developments. Conference Call Preregistration Participant Online Registration: https://register.vevent.com/register/BI571290b28e04470f8c18382c10e6680e Please...

Continue reading

Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025

LONDON, March 06, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2024 financial results and operational highlights before open of US markets on Thursday, March 20, 2025. Management will host a conference call and webcast at 8:30 am EDT/12:30 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.  About Autolus...

Continue reading

Conavi Medical Announces Uplisting to OTCQB Venture Market

– Expected to enhance visibility and access to U.S. investors – Trading to commence on March 6, 2025 TORONTO, March 06, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that its common shares have been approved for uplisting from the OTC Pink Open Market to the OTCQB Venture Market, with trading set to commence on March 6, 2025. The ticker symbol will remain CNVIF, and no action is needed by shareholders. Trading on the OTCQB is expected to complement the Company’s existing listing on the TSX Venture Exchange. “As we move toward commercial launch of our next-generation...

Continue reading

Questor Announces Sale of Clean Combustion Solution

CALGARY, Alberta, March 06, 2025 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor”, the “Company”), (TSX Venture Exchange: QST) announced today a $0.9 million purchase order to supply a clean combustion solution to manage a variety of railcar vapours at a Caltrax Inc. full-service railcar repair and maintenance facility in Calgary. Questor’s partnership with Caltrax highlights the versatility of Questor’s clean combustion units, used in this application to safely and cleanly combust hydrocarbon vapours in urban settings, such as Calgary. Questor’s ISO 14034-certified clean combustion units are engineered to safely manage rail car vapours through a variety of waste gas compositions, eliminating methane and other harmful pollutants at a 99.99% combustion efficiency. These units meet and exceed the most stringent global emissions...

Continue reading

Rego Payment Architectures, Inc. Announces Its White-Label Senior Financial Management Product To Be Available End of March 2025

Financial institutions will be able to launch banking products in their own brand that provide oversight and insight into elderly financial health to their caretakers BLUE BELL, Pa., March 06, 2025 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), the leading white-label family financial lifecycle solution platform, today announced the upcoming launch of a first-of-its-kind white-labeled senior financial management (SFM) product that enables banks and credit unions to help protect the financial well-being of senior citizens. REGO’s SFM product allows financial institutions to deploy an integrated branded solution that provides caretakers and fiduciaries with critical oversight and insight into their loved ones’ financial activity and help guard against fraud – even if they bank at different institutions. Financial...

Continue reading

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported that, on March 3, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”) granted the Company an extension in which to regain compliance with all continued listing rules of The Nasdaq Capital Market. The Panel’s determination follows a hearing on February 13, 2025, at which the Panel considered the Company’s plan to regain compliance with Listing Rules 5450(a)(1), 5450(b)(2)(A) and 5450(b)(2&3)(C), the minimum bid price (“Bid Price”), the market value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.